Construction and Preclinical Evaluation of <sup>124</sup>I/<sup>125</sup>I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3
2024 · Molecular Pharmaceutics · 10 citations
https://doi.org/10.1021/acs.molpharmaceut.3c01046
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
51
Citations
4
h-index
2
i10-index
Jinping Tao is an academic researcher from Peking University. The author has contributed to research in topics: Radiopharmaceutical Chemistry and Applications & Cancer Immunotherapy and Biomarkers & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 4, co-authored 8 publications.
https://doi.org/10.1021/acs.molpharmaceut.3c01046
https://doi.org/10.1007/s44178-025-00212-1
https://doi.org/10.1021/acs.bioconjchem.5c00041
Click to start Chat